Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001232524-13-000032
Filing Date
2013-05-07
Accepted
2013-05-07 17:25:35
Documents
11
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q jazz2013q1doc.htm 10-Q 1165112
2 JAZZ PHARMACEUTICALS PLC 2013 EXECUTIVE OFFICER COMPENSATION ARRANGEMENTS jazzq12013ex106.htm EX-10.6 15754
3 CERTIFICATION OF CEO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) jazzq12013ex311.htm EX-31.1 12772
4 CERTIFICATION OF CFO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) jazzq12013ex312.htm EX-31.2 12222
5 CERTIFICATIONS OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350 jazzq12013ex321.htm EX-32.1 7920
  Complete submission text file 0001232524-13-000032.txt   7297203

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT jazz-20130331.xml EX-101.INS 1086993
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jazz-20130331.xsd EX-101.SCH 47453
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT jazz-20130331_cal.xml EX-101.CAL 104158
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jazz-20130331_def.xml EX-101.DEF 184139
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jazz-20130331_lab.xml EX-101.LAB 610479
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jazz-20130331_pre.xml EX-101.PRE 337580
Mailing Address 4TH FLOOR, CONNAUGHT HOUSE ONE BURLINGTON ROAD DUBLIN L2 4
Business Address 4TH FLOOR, CONNAUGHT HOUSE ONE BURLINGTON ROAD DUBLIN L2 4 353-1-634-4183
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

EIN.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33500 | Film No.: 13821368
SIC: 2834 Pharmaceutical Preparations